Skip to main content
Mitchell Felder, MD, Neurology, Sayre, PA, UPMC Altoona

MitchellSFelderMD

Neurology Sayre, PA

Physician

Dr. Felder is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Felder's full profile

Already have an account?

Education & Training

  • Westchester Medical Center
    Westchester Medical CenterResidency, Neurology, 1985 - 1988
  • Hackensack University Medical Center/Englewood Hospital and Medical Center
    Hackensack University Medical Center/Englewood Hospital and Medical CenterInternship, Internal Medicine, 1984 - 1985
  • Sapienza University of Rome
    Sapienza University of RomeClass of 1983

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2019 - 2025
  • FL State Medical License
    FL State Medical License 2005 - 2025
  • PA State Medical License
    PA State Medical License 1988 - 2024
  • SC State Medical License
    SC State Medical License 2016 - 2023
  • NM State Medical License
    NM State Medical License 2018 - 2022
  • MT State Medical License
    MT State Medical License 2018 - 2022
  • NJ State Medical License
    NJ State Medical License 1985 - 1989
  • American Board of Psychiatry and Neurology Neurology

Press Mentions

  • Halberd Corporation Advisory Board Reorganization Announced
    Halberd Corporation Advisory Board Reorganization AnnouncedDecember 1st, 2020
  • Premier Biomedical Signs Joint Venture Agreement with New Earth Development, RushNet Inc., and XYZ Hemp, Inc. To Market New Anti-Addiction Patch
    Premier Biomedical Signs Joint Venture Agreement with New Earth Development, RushNet Inc., and XYZ Hemp, Inc. To Market New Anti-Addiction PatchJuly 30th, 2019
  • Premier Biomedical's Research on Its Patent Pending Anti-Cancer Treatment with Metronomic Chemotherapy Recognized for Publication in the Prestigious British Journal of Cancer
    Premier Biomedical's Research on Its Patent Pending Anti-Cancer Treatment with Metronomic Chemotherapy Recognized for Publication in the Prestigious British Journal of CancerDecember 6th, 2016

Hospital Affiliations